Samuel D Isaly - Net Worth and Insider Trading
Samuel D Isaly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel D Isaly owns 43 companies in total, including Xtant Medical Holdings Inc (XTNT) , Kala Bio Inc (KALA) , and Pieris Pharmaceuticals Inc (PIRS) among others .
Click here to see the complete history of Samuel D Isaly’s form 4 insider trades.
Insider Ownership Summary of Samuel D Isaly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XTNT | Xtant Medical Holdings Inc | 2018-01-17 | 10 percent owner |
| KALA | Kala Bio Inc | 2017-07-25 | 10 percent owner & other: See Remarks |
| PIRS | Pieris Pharmaceuticals Inc | 2015-07-06 | director & 10 percent owner |
 | | 2017-12-08 | director |
| | 2017-11-16 | 10 percent owner |
| | 2017-11-15 | 10 percent owner |
| | 2017-10-04 | 10 percent owner |
| | 2017-10-03 | 10 percent owner |
| | 2017-09-29 | 10 percent owner |
| | 2016-08-03 | director |
| | 2017-08-28 | director |
| | 2017-07-24 | director |
| | 2017-06-09 | 10 percent owner |
| | 2017-04-25 | 10 percent owner |
| | 2016-05-20 | director |
| | 2017-03-15 | director & 10 percent owner |
| | 2017-02-16 | 10 percent owner |
| | 2016-08-22 | director & 10 percent owner |
| | 2016-12-30 | director & 10 percent owner |
| | 2016-11-29 | director & 10 percent owner |
| | 2016-07-22 | 10 percent owner |
| | 2016-06-27 | director & 10 percent owner |
| | 2016-05-18 | director |
| | 2016-05-05 | 10 percent owner |
| | 2015-11-17 | director |
| | 2015-10-27 | director & 10 percent owner |
| | 2014-10-28 | 10 percent owner |
| | 2015-07-15 | director |
| | 2013-04-09 | director & 10 percent owner |
| | 2013-07-12 | 10 percent owner |
| | 2013-09-24 | other: Former 10% Owner |
| | 2012-04-30 | 10 percent owner |
| | 2013-01-30 | director |
| | 2011-01-01 | director & 10 percent owner |
| | 2011-02-02 | 10 percent owner |
| | 2012-02-08 | 10 percent owner |
| | 2008-05-13 | director & 10 percent owner |
| | 2010-12-09 | director |
| | 2010-04-30 | 10 percent owner |
| | 2008-02-12 | director & 10 percent owner |
| | 2009-05-22 | 10 percent owner |
| | 2007-05-14 | director |
| | 2017-03-15 | director & 10 percent owner |
Samuel D Isaly Trading Performance
Samuel D Isaly Ownership Network
Samuel D Isaly Owned Company Details
What does Xtant Medical Holdings Inc do?
Who are the key executives at Xtant Medical Holdings Inc?
Samuel D Isaly is the 10 percent owner of Xtant Medical Holdings Inc. Other key executives at Xtant Medical Holdings Inc include VP & Chief Commercial Officer Kevin D Brandt , Interim CFO Scott C Neils , and Chief Operations Officer Mark A. Schallenberger .
Xtant Medical Holdings Inc (XTNT) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Xtant Medical Holdings Inc (XTNT). Other recent insider transactions involving Xtant Medical Holdings Inc (XTNT) include a net purchase of 41,670 shares made by Kevin D Brandt ,
In summary, during the past 3 months, insiders sold 0 shares of Xtant Medical Holdings Inc (XTNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xtant Medical Holdings Inc (XTNT) were sold and 41,670 shares were bought by its insiders, resulting in a net purchase of 41,670 shares.
Xtant Medical Holdings Inc (XTNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xtant Medical Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Kala Bio Inc do?
Who are the key executives at Kala Bio Inc?
Samuel D Isaly is the 10 percent owner & other: See Remarks of Kala Bio Inc. Other key executives at Kala Bio Inc include CHIEF BUSINESS OFFICER Darius Kharabi , Chief Financial Officer Mary Reumuth , and Chief Medical Officer Romulus K Brazzell .
Kala Bio Inc (KALA) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 27,099 shares made by Mark T Iwicki , a net sale of 9,108 shares made by Romulus K Brazzell , and a net sale of 8,151 shares made by Todd Bazemore .
In summary, during the past 3 months, insiders sold 0 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 59,535 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 59,535 shares.
Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kala Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Samuel D Isaly is the director & 10 percent owner of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , 10 percent owner Bvf I Gp Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Samuel D Isaly is the director of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Samuel D Isaly is the 10 percent owner of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 500,000 shares made by Orbimed Advisors Llc ,
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 500,000 shares were bought by its insiders, resulting in a net purchase of 500,000 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does X4 Pharmaceuticals Inc do?
Who are the key executives at X4 Pharmaceuticals Inc?
Samuel D Isaly is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .
X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 614,040 shares made by Paula Ragan , a net sale of 159,766 shares made by Mary Dibiase , and a net sale of 541,511 shares made by Adam S. Mostafa .
In summary, during the past 3 months, insiders sold 689,617 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 689,617 shares. During the past 18 months, 1,626,394 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,394 shares.
X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
X4 Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Samuel D Isaly is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include EVP & Head of North America Jennifer Chien , Chief Technical Officer Joseph Shulman , and Chief Human Resources Officer Pamela J. Cramer .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 184,943 shares made by Joseph Shulman , a net sale of 145,755 shares made by Jennifer Chien , and a net sale of 85,162 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 89,517 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 89,517 shares. During the past 18 months, 672,183 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,183 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Sorrento Tech Inc do?
Who are the key executives at Sorrento Tech Inc?
Samuel D Isaly is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Orbimed Advisors Llc , and director & 10 percent owner M James Barrett .
Sorrento Tech Inc (ROKA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sorrento Tech Inc Insider Transactions
- Download to Excel(.xls)
What does Audentes Therapeutics Inc do?
Who are the key executives at Audentes Therapeutics Inc?
Samuel D Isaly is the 10 percent owner of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , SVP & Chief Medical Officer Edward R. Conner , and Executive Vice President & CFO Thomas P Soloway .
Audentes Therapeutics Inc (BOLD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Audentes Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Glaukos Corp do?
Who are the key executives at Glaukos Corp?
Samuel D Isaly is the director of Glaukos Corp. Other key executives at Glaukos Corp include CFO & SVP Corporate Development Joseph E Gilliam , SVP & Chief Financial Officer Alex R. Thurman , and director & 10 percent owner & Chief Executive Officer Thomas William Burns .
Glaukos Corp (GKOS) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 314,757 shares made by Joseph E Gilliam , a net sale of 471,810 shares made by Thomas William Burns , and a net sale of 6,762 shares made by Alex R. Thurman .
In summary, during the past 3 months, insiders sold 17,603 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 17,603 shares. During the past 18 months, 909,236 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 909,236 shares.
Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Glaukos Corp Insider Transactions
- Download to Excel(.xls)
What does Synlogic Inc do?
Who are the key executives at Synlogic Inc?
Samuel D Isaly is the director of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .
Synlogic Inc (SYBX) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .
In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.
Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synlogic Inc Insider Transactions
- Download to Excel(.xls)
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Samuel D Isaly is the director of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Samuel D Isaly is the 10 percent owner of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
- Download to Excel(.xls)
What does SteadyMed Ltd do?
Who are the key executives at SteadyMed Ltd?
Samuel D Isaly is the 10 percent owner of SteadyMed Ltd. Other key executives at SteadyMed Ltd include 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp Vi Llc , and director & 10 percent owner Brian Jay Stark .
SteadyMed Ltd (STDY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.
SteadyMed Ltd Insider Transactions
- Download to Excel(.xls)
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Samuel D Isaly is the director of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 70,989 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,531 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,531 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Aerpio Pharmaceuticals Inc do?
Who are the key executives at Aerpio Pharmaceuticals Inc?
Samuel D Isaly is the director & 10 percent owner of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .
Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerpio Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
Samuel D Isaly is the 10 percent owner of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .
In summary, during the past 3 months, insiders sold 7,000 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ViewRay Inc do?
Who are the key executives at ViewRay Inc?
Samuel D Isaly is the director & 10 percent owner of ViewRay Inc. Other key executives at ViewRay Inc include SVP & General Counsel Sanket Shah , 10 percent owner Farhad Fred Ebrahimi , and Chief Commercial Officer Paul Jr Ziegler .
ViewRay Inc (VRAYQ) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in ViewRay Inc (VRAYQ). Other recent insider transactions involving ViewRay Inc (VRAYQ) include a net sale of 110,324 shares made by B Kristine Johnson , a net sale of 8,203,610 shares made by Farhad Fred Ebrahimi , and a net sale of 2,408,747 shares made by Scott William Drake .
In summary, during the past 3 months, insiders sold 0 shares of ViewRay Inc (VRAYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,487,227 shares of ViewRay Inc (VRAYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,487,227 shares.
ViewRay Inc (VRAYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
ViewRay Inc Insider Transactions
- Download to Excel(.xls)
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Samuel D Isaly is the director & 10 percent owner of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Response Biomedical Corp do?
Who are the key executives at Response Biomedical Corp?
Samuel D Isaly is the director & 10 percent owner of Response Biomedical Corp. Other key executives at Response Biomedical Corp include director & 10 percent owner Orbimed Advisors Llc , director & 10 percent owner Peter A. Thompson , and director & 10 percent owner Orbimed Capital Gp Iii Llc .
Response Biomedical Corp (RPBIF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Response Biomedical Corp (RPBIF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Response Biomedical Corp (RPBIF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Response Biomedical Corp (RPBIF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Response Biomedical Corp Insider Transactions
- Download to Excel(.xls)
What does Relypsa Inc do?
Who are the key executives at Relypsa Inc?
Samuel D Isaly is the 10 percent owner of Relypsa Inc. Other key executives at Relypsa Inc include SVP & Chief Commercial Officer J. Scott Garland , SVP & Chief Technology Officer Wilhelm Stahl , and See Remarks Ronald A. Krasnow .
Relypsa Inc (RLYP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Relypsa Inc (RLYP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relypsa Inc (RLYP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Relypsa Inc (RLYP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relypsa Inc Insider Transactions
- Download to Excel(.xls)
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Samuel D Isaly is the director & 10 percent owner of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,921,182 shares made by Timothy A Springer , a net sale of 52,115 shares made by , and a net purchase of 7,500 shares made by Timothy C Barabe .
In summary, during the past 3 months, insiders sold 241,836 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 689,850 shares, with a net purchase of 448,014 shares. During the past 18 months, 241,957 shares of Cartesian Therapeutics Inc (RNAC) were sold and 746,143 shares were bought by its insiders, resulting in a net purchase of 504,186 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Corvus Pharmaceuticals Inc do?
Who are the key executives at Corvus Pharmaceuticals Inc?
Samuel D Isaly is the director of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , See Remarks William Benton Jones , and Chief Financial Officer Leiv Lea .
Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Corvus Pharmaceuticals Inc (CRVS). Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 577,634 shares made by Miller Richard A Md , and a net purchase of 20,000 shares made by William Benton Jones .
In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 597,634 shares were bought by its insiders, resulting in a net purchase of 597,634 shares.
Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corvus Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Samuel D Isaly is the 10 percent owner of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 5,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 57,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 57,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Otonomy Inc do?
Who are the key executives at Otonomy Inc?
Samuel D Isaly is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .
Otonomy Inc (OTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Otonomy Inc Insider Transactions
- Download to Excel(.xls)
What does Dimension Therapeutics Inc do?
Who are the key executives at Dimension Therapeutics Inc?
Samuel D Isaly is the director & 10 percent owner of Dimension Therapeutics Inc. Other key executives at Dimension Therapeutics Inc include other: See Remark 1 Fmr Llc , director & President and CEO Annalisa Jenkins , and Chief Operating Officer Mary Thistle .
Dimension Therapeutics Inc (DMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dimension Therapeutics Inc (DMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dimension Therapeutics Inc (DMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dimension Therapeutics Inc (DMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dimension Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Sientra Inc do?
Who are the key executives at Sientra Inc?
Samuel D Isaly is the 10 percent owner of Sientra Inc. Other key executives at Sientra Inc include director & President and CEO Ronald Menezes , General Counsel and VP Oliver Christian Bennett , and Chief Financial Officer Andrew C Schmidt .
Sientra Inc (SIENQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sientra Inc (SIENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sientra Inc (SIENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sientra Inc (SIENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sientra Inc Insider Transactions
- Download to Excel(.xls)
What does Sierra Oncology Inc do?
Who are the key executives at Sierra Oncology Inc?
Samuel D Isaly is the director of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .
Sierra Oncology Inc (SRRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sierra Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Intercept Pharmaceuticals Inc do?
Who are the key executives at Intercept Pharmaceuticals Inc?
Samuel D Isaly is the director & 10 percent owner of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .
Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intercept Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Samuel D Isaly is the 10 percent owner of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 7,903 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,810 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,514,927 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Acceleron Pharma Inc do?
Who are the key executives at Acceleron Pharma Inc?
Samuel D Isaly is the other: Former 10% Owner of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .
Acceleron Pharma Inc (XLRN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acceleron Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
Samuel D Isaly is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , director & President & CEO Jack A. Khattar , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 120,000 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 21,235 shares made by Tami Tillotson Martin .
In summary, during the past 3 months, insiders sold 330,917 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 330,917 shares. During the past 18 months, 477,246 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 477,246 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Anthera Pharmaceuticals Inc do?
Who are the key executives at Anthera Pharmaceuticals Inc?
Samuel D Isaly is the director of Anthera Pharmaceuticals Inc. Other key executives at Anthera Pharmaceuticals Inc include Chief Medical Officer Shanahan William R Jr , Chief Regulatory Officer Klara Dickinson , and Chief Technology Officer Charles V Olson .
Anthera Pharmaceuticals Inc (ANTH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Anthera Pharmaceuticals Inc (ANTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anthera Pharmaceuticals Inc (ANTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Anthera Pharmaceuticals Inc (ANTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anthera Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Amarin Corp PLC do?
Who are the key executives at Amarin Corp PLC?
Samuel D Isaly is the director & 10 percent owner of Amarin Corp PLC. Other key executives at Amarin Corp PLC include EVP & President US Aaron Berg , director & See Remarks Patrick Holt , and Chief Scientific Officer Steven B Ketchum .
Amarin Corp PLC (AMRN) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Amarin Corp PLC (AMRN). Other recent insider transactions involving Amarin Corp PLC (AMRN) include a net purchase of 314,426 shares made by Patrick Holt , a net purchase of 160,000 shares made by Aaron Berg , and a net sale of 34,131 shares made by Steven B Ketchum .
In summary, during the past 3 months, insiders sold 0 shares of Amarin Corp PLC (AMRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 34,131 shares of Amarin Corp PLC (AMRN) were sold and 474,426 shares were bought by its insiders, resulting in a net purchase of 440,295 shares.
Amarin Corp PLC (AMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amarin Corp PLC Insider Transactions
- Download to Excel(.xls)
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Samuel D Isaly is the 10 percent owner of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 8,793 shares made by Jonathan Slonin , a net purchase of 8,312 shares made by Marcelo Bigal , and a net sale of 2,000 shares made by Daryl Gaugler .
In summary, during the past 3 months, insiders sold 500 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 143,570 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 122,594 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
- Download to Excel(.xls)
What does ChemoCentryx Inc do?
Who are the key executives at ChemoCentryx Inc?
Samuel D Isaly is the 10 percent owner of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , director & 10 percent owner & President & CEO and Director Thomas J. Schall , and SVP & Finance & Acctg Officer Yi Ching Yau .
ChemoCentryx Inc (CCXI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
ChemoCentryx Inc Insider Transactions
- Download to Excel(.xls)
What does Athersys Inc do?
Who are the key executives at Athersys Inc?
Samuel D Isaly is the director & 10 percent owner of Athersys Inc. Other key executives at Athersys Inc include director & Chief Executive Officer Daniel A. Camardo , Chief Operating Officer Maia Hansen , and Interim & CFO Kasey Rosado .
Athersys Inc (ATHXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Athersys Inc (ATHXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athersys Inc (ATHXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Athersys Inc (ATHXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athersys Inc Insider Transactions
- Download to Excel(.xls)
What does NxStage Medical Inc do?
Who are the key executives at NxStage Medical Inc?
Samuel D Isaly is the director of NxStage Medical Inc. Other key executives at NxStage Medical Inc include director & Chief Executive Officer Jeffrey H Burbank , Chief Accounting Officer Kevin Hershberger , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .
NxStage Medical Inc (NXTM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NxStage Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Kun Run Biotechnology Inc do?
Who are the key executives at Kun Run Biotechnology Inc?
Samuel D Isaly is the 10 percent owner of Kun Run Biotechnology Inc. Other key executives at Kun Run Biotechnology Inc include and 10 percent owner Orbimed Advisors Llc .
Kun Run Biotechnology Inc (KURU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kun Run Biotechnology Inc (KURU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kun Run Biotechnology Inc (KURU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kun Run Biotechnology Inc (KURU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kun Run Biotechnology Inc Insider Transactions
- Download to Excel(.xls)
What does Albireo Pharma Inc do?
Who are the key executives at Albireo Pharma Inc?
Samuel D Isaly is the director & 10 percent owner of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , CFO and Treasurer Harford Simon N.r. , and Chief Commercial Officer Pamela Stephenson .
Albireo Pharma Inc (ALBO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Albireo Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does ARYx Therapeutics Inc do?
Who are the key executives at ARYx Therapeutics Inc?
Samuel D Isaly is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .
ARYx Therapeutics Inc (ARYX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYx Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Insulet Corp do?
Who are the key executives at Insulet Corp?
Samuel D Isaly is the director of Insulet Corp. Other key executives at Insulet Corp include SVP & R&D & New Prod Dev. & Comm Eric Benjamin , VP & CAO and Controller Lauren Budden , and SVP & Chief Technology Officer Mark N Field .
Insulet Corp (PODD) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Insulet Corp (PODD). Other recent insider transactions involving Insulet Corp (PODD) include a net sale of 6,401 shares made by Mark N Field , a net sale of 15,300 shares made by Timothy J Scannell , and a net sale of 940 shares made by Luciana Borio .
In summary, during the past 3 months, insiders sold 5,785 shares of Insulet Corp (PODD) in total and bought 0 shares, with a net sale of 5,785 shares. During the past 18 months, 86,873 shares of Insulet Corp (PODD) were sold and 5,651 shares were bought by its insiders, resulting in a net sale of 81,222 shares.
Insulet Corp (PODD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Insulet Corp Insider Transactions
- Download to Excel(.xls)
What does Aadi Bioscience Inc do?
Who are the key executives at Aadi Bioscience Inc?
Samuel D Isaly is the director & 10 percent owner of Aadi Bioscience Inc. Other key executives at Aadi Bioscience Inc include director & Chief Executive Officer David James Lennon , director & See Remarks Neil Desai , and Chief Financial Officer Scott M. Giacobello .
Aadi Bioscience Inc (AADI) Insider Trades Summary
Over the past 18 months, Samuel D Isaly made no insider transaction in Aadi Bioscience Inc (AADI). Other recent insider transactions involving Aadi Bioscience Inc (AADI) include a net sale of 618,000 shares made by Neil Desai , and a net sale of 9,689 shares made by David James Lennon .
In summary, during the past 3 months, insiders sold 9,689 shares of Aadi Bioscience Inc (AADI) in total and bought 0 shares, with a net sale of 9,689 shares. During the past 18 months, 627,689 shares of Aadi Bioscience Inc (AADI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 627,689 shares.
Aadi Bioscience Inc (AADI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aadi Bioscience Inc Insider Transactions
- Download to Excel(.xls)
Samuel D Isaly Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel D Isaly. You might contact Samuel D Isaly via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
